Status:
COMPLETED
Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder
Lead Sponsor:
Samsung Medical Center
Conditions:
Panic Disorder
Eligibility:
All Genders
20-60 years
Phase:
PHASE4
Brief Summary
Panic disorder is one of the most prevalent and disabling psychiatric disorders. Brain regions such as amygdala, hippocampus, periaqueductal gray (PAG), locus coeruleus, parahippocampal gyrus, frontal...
Eligibility Criteria
Inclusion
- panic disorder 20-60 years
Exclusion
- history of major psychosis (schizophrenia or bipolar disorder), social phobia, obsessive-compulsive disorder, and generalized anxiety disorder, and posttraumatic stress disorder, alcohol abuse and dependence, current regular use of benzodiazepines
- less than 17 on the HAM-D
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00767754
Start Date
January 1 2007
End Date
December 1 2008
Last Update
July 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710